2024-03-07T03:43:23.166Z

XL092-304

XL092-304
Kidney cancer

A study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma (STELLAR-304)

A study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma (STELLAR-304)

Trial overview

Topic

Kidney cancer

Trial registration

Number: NCT05678673

Study details

This is a multicenter, randomized (2:1), open-label, controlled Phase 3 trial of XL092 in combination with nivolumab versus sunitinib in subjects with unresectable, locally advanced or metastatic nccRCC who have not received prior systemic anticancer therapy.

Further information

Click here for further information

Location

GenesisCare Cavalry Central Districts – PI: Mark McGregor

GenesisCare Cavalry Central Districts – PI: Mark McGregor :::

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.